	Managing auditory hallucination symptoms in patients with schizophrenia in China: a best practice implementation project. JBI Evid Implement Jin X, Shen T, Wang Y, Cai J, Dai Z, Li L, Shi Z, Huang C. PMID: 42163558 [PubMed - as supplied by publisher]
	Advances in schizophrenia research and treatment: exploring neurotransmitter imbalances, genetics, and innovative therapies. Prog Neuropsychopharmacol Biol Psychiatry , Fi, Hroudová J. PMID: 42162691 [PubMed - as supplied by publisher]
	Rethinking schizophrenia: insights from genomics and implications for research. Mol Psychiatry Owen MJ, O'Donovan MC. PMID: 42162224 [PubMed - as supplied by publisher]
	High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic Setting. Pharmacopsychiatry Hart XM, Hirjak D, Eap CB, Eichentopf L, Fritze S, Lense XM, Scharf D, Schilling C, Schwind N, Post P, Wesner K, Gründer G. PMID: 42161261 [PubMed - as supplied by publisher]
	Short-term development of neurocognition in early-stage schizophrenia with predominant negative symptoms. Psychiatry Res Yang Y, Zhu Y, Wu R, Jiang F, Cao D. PMID: 42161032 [PubMed - as supplied by publisher]
	A mixed methods study of program-level factors influencing patient and family engagement in first episode psychosis coordinated specialty care. Schizophr Res Foo CYS, Leonard CJ, McLaughlin MM, Johnson KA, Öngür D, Mueser KT, Cather C. PMID: 42160903 [PubMed - as supplied by publisher]
	Heat Shock Proteins in Schizophrenia: Integrating Stress Responses, Molecular Pathways, and Emerging Therapeutic Strategies. Neuroscientist Ebrahimi MN, Banazadeh M, Kohlmeier KA, Shabani M. PMID: 42159268 [PubMed - as supplied by publisher]
	Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification. J Psychiatry Neurosci Han Y, Du Y, Xia Y, Hua L, Yao Z, Lu Q. PMID: 42159174 [PubMed - indexed for MEDLINE]
	PSPH and CXCL2 Predict Treatment Response in First-Episode Schizophrenia: a Retrospective Study. Clin Lab Zheng J. PMID: 42159130 [PubMed - indexed for MEDLINE]
	Association of nitric oxide and neurotrophin-3 with cognitive dysfunction in schizophrenia spectrum disorders (SSD): A cross-sectional comparative study. Indian J Psychiatry Periasamy T, Murugiah V, Thankamoni RK, Alexander H, Gurusamy HM, Stanley RRB. PMID: 42158510 [PubMed]
	Stability-Driven Selection of EEG Connectivity Features for Psychosis Classification: A Network-Based Machine Learning Approach. CNS Neurosci Ther Naeim M, Narimani M. PMID: 42157703 [PubMed - indexed for MEDLINE]
	Key Stakeholder Perspectives on Help-Seeking for Psychosis in South and Southeast Asia: A Systematic Mixed-Studies Review and Narrative Synthesis. Int J Ment Health Nurs Aurizki GE, Griffiths R, Renwick L. PMID: 42157637 [PubMed - indexed for MEDLINE]
	Influence of Age and Gender on Short-Term Efficacy, Acceptability and Safety of Antipsychotic Drug Treatment of Adolescents With Schizophrenia: An Individual Patient Data Meta-Analysis. J Am Acad Child Adolesc Psychiatry Storosum BWC, Cohen SE, Tilkema N, Mattila T, van den Brink W, de Haan L, Denys DAJP, Zantvoord JB. PMID: 42155624 [PubMed - as supplied by publisher]
	Plasma metabolomic signature of frailty and risk of late-onset schizophrenia: A prospective cohort study. Schizophr Res Sun L, Bo Y, Li D, Yao P, Sun Z, Cai Q, Chang H, Cheng M, Xue M, Yu Z, Zhu Y, Zhao X. PMID: 42155165 [PubMed - as supplied by publisher]
	Impact of Obstetric Complications in Subjects at Clinical High Risk for Psychosis: A Systematic Review and Meta-Analysis. Acta Psychiatr Scand Baeza I, Tor J, de la Serna E, Sugranyes G, Crispi F, Izquierdo-Renau M, Del Olmo M, Dolz M, García-Rizo C. PMID: 42154536 [PubMed - indexed for MEDLINE]
	Effect of meditation on clinical symptoms and gray matter volume in chronic schizophrenia: a randomized controlled trial. Eur Arch Psychiatry Clin Neurosci Yang M, Ma Y, Huang J, Huang Y, Liu L, Li Z, Cui D. PMID: 42154270 [PubMed - as supplied by publisher]
	Efficacy and safety of Nrf2 activators for schizophrenia: a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci Okazaki M, Sakuma K, Jo H, Nagata Y, Hamanaka S, Nishii Y, Kitajima T, Iwata N, Kishi T. PMID: 42154264 [PubMed - as supplied by publisher]
	Randomized Controlled Trial on the Effects of Metacognitive Training (MCT) in a Sample of Patients With Recent Onset Psychosis: Study of the Impact on the Severity and Dimensions of Delusions, Self-Esteem and Depression. Clin Psychol Psychother Lorente-Rovira E, Luengo A, Barrigón ML, Carrilero RL, Pousa E, Grasa E, Barajas A, Ruiz-Delgado I, Cid J, Gonzalez-Higueras F, Guasp A, Llácer B, Escartí MJ, Carbonell-Asins JA, Moritz S, Sanjuán J, Ochoa S, Metacognition Study Group. PMID: 42152571 [PubMed - indexed for MEDLINE]
	The relationship between ABO blood group and schizophrenia: An analysis based on a Chinese survey. Medicine (Baltimore) Yu K, Bao H, Jiang H, Li D, Chen Z. PMID: 42152393 [PubMed - indexed for MEDLINE]
	Is problematic sexuality a marker for the onset of mental disorders? A cross-sectional study on psychotic-like experiences and sexual behaviour in a non-clinical sample. J Psychiatr Res Doroldi D, Origlia G, Giannini T, Jannini TB, Boldrini T, Del Casale A, Lo Buglio G, Spitoni G, Limoncin E, Pelizza L, Ciocca G. PMID: 42150511 [PubMed - as supplied by publisher]

Articles 1 - 20 / 68857

Page 1 of 3443



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy